These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 15113848)

  • 21. Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice.
    Li X; Risbrough VB; Cates-Gatto C; Kaczanowska K; Finn MG; Roberts AJ; Markou A
    Neuropharmacology; 2013 Jul; 70():156-67. PubMed ID: 23376712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation but not blockade of GABAB receptors during early-life alters anxiety in adulthood in BALB/c mice.
    Sweeney FF; O'Leary OF; Cryan JF
    Neuropharmacology; 2014 Jun; 81():303-10. PubMed ID: 24050962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization.
    Decker MW; Brioni JD; Sullivan JP; Buckley MJ; Radek RJ; Raszkiewicz JL; Kang CH; Kim DJ; Giardina WJ; Wasicak JT
    J Pharmacol Exp Ther; 1994 Jul; 270(1):319-28. PubMed ID: 7913497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.
    Ring RH; Schechter LE; Leonard SK; Dwyer JM; Platt BJ; Graf R; Grauer S; Pulicicchio C; Resnick L; Rahman Z; Sukoff Rizzo SJ; Luo B; Beyer CE; Logue SF; Marquis KL; Hughes ZA; Rosenzweig-Lipson S
    Neuropharmacology; 2010 Jan; 58(1):69-77. PubMed ID: 19615387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice.
    Quéva C; Bremner-Danielsen M; Edlund A; Ekstrand AJ; Elg S; Erickson S; Johansson T; Lehmann A; Mattsson JP
    Br J Pharmacol; 2003 Sep; 140(2):315-22. PubMed ID: 12970075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABA
    Kalinichev M; Girard F; Haddouk H; Rouillier M; Riguet E; Royer-Urios I; Mutel V; Lütjens R; Poli S
    Neuropharmacology; 2017 Mar; 114():34-47. PubMed ID: 27889489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
    J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
    Revel L; Mennuni L; Garofalo P; Makovec F
    Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse cerebellar GABAB participation in the expression of acute ethanol-induced ataxia and in its modulation by the cerebellar adenosinergic A1 system.
    Dar MS
    Brain Res Bull; 1996; 41(1):53-9. PubMed ID: 8883916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-periaqueductal gray matter injections of midazolam fail to alter anxiety in plus-maze experienced mice.
    dos Reis LM; Canto-de-Souza A
    Brain Res; 2008 Sep; 1231():93-102. PubMed ID: 18621039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.
    Gjoni T; Urwyler S
    Eur J Pharmacol; 2009 Jan; 603(1-3):37-41. PubMed ID: 19109945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor activation involving positive allosteric modulation, unlike full agonism, does not result in GABAB receptor desensitization.
    Gjoni T; Urwyler S
    Neuropharmacology; 2008 Dec; 55(8):1293-9. PubMed ID: 18775443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
    McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
    Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action.
    Lehmann A; Antonsson M; Holmberg AA; Blackshaw LA; Brändén L; Bräuner-Osborne H; Christiansen B; Dent J; Elebring T; Jacobson BM; Jensen J; Mattsson JP; Nilsson K; Oja SS; Page AJ; Saransaari P; von Unge S
    J Pharmacol Exp Ther; 2009 Nov; 331(2):504-12. PubMed ID: 19648470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors.
    Griebel G; Perrault G; Simiand J; Cohen C; Granger P; Decobert M; Françon D; Avenet P; Depoortere H; Tan S; Oblin A; Schoemaker H; Evanno Y; Sevrin M; George P; Scatton B
    J Pharmacol Exp Ther; 2001 Aug; 298(2):753-68. PubMed ID: 11454940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
    Li X; Kaczanowska K; Finn MG; Markou A; Risbrough VB
    Neuropharmacology; 2015 Oct; 97():357-64. PubMed ID: 26002628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticonvulsant effects of structurally diverse GABA(B) positive allosteric modulators in the DBA/2J audiogenic seizure test: Comparison to baclofen and utility as a pharmacodynamic screening model.
    Brown JW; Moeller A; Schmidt M; Turner SC; Nimmrich V; Ma J; Rueter LE; van der Kam E; Zhang M
    Neuropharmacology; 2016 Feb; 101():358-69. PubMed ID: 26471422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The motor-impairing effects of GABA(A) and GABA(B) agonists in gamma-hydroxybutyrate (GHB)-treated rats: cross-tolerance to baclofen but not flunitrazepam.
    Smith MA; Gergans SR; Lyle MA
    Eur J Pharmacol; 2006 Dec; 552(1-3):83-9. PubMed ID: 17026996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiolytic-like activity of SB-205384 in the elevated plus-maze test in mice.
    Navarro JF; Burón E; Martín-López M
    Psicothema; 2006 Feb; 18(1):100-4. PubMed ID: 17296016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.